Otezla (apremilast) is an oral, selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
New research indicates that doctors who treat anaphylaxis with intravenous epinephrine rather than intramuscular or subcutaneous injections are increasing the risk that patients will suffer overdoses or other adverse reactions.
Anil Asgaonkar, MD, provides a basic overview of the signs, symptoms, and causes frequently associated with hyponatremia, and outlines several standard treatment approaches.
The US National Institutes of Health is investing $10 million in additional funding in scientific trials to encourage researchers to consider gender in their preclinical and clinical studies.
Researchers in Wisconsin recently announced the discovery of a gene which could help explain certain traits seen in patients diagnosed with diabetes.
Efforts to reduce overuse of non-intensive care unit cardiac telemetry correlate with reductions in telemetry use and considerable cost savings, according to a research letter published online Sept. 22 in JAMA Internal Medicine.
A new study warns that rising temperatures and altered weather patterns in the United States may soon exacerbate many existing health risks. The study was published online Sept. 22 in the Journal of the American Medical Association, ahead of the United Nations' summit on climate change, which kicks off Tuesday in New York City.